BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cipla
Johnson and Johnson
QuintilesIMS
Boehringer Ingelheim
Medtronic
Moodys
AstraZeneca
US Department of Justice
Farmers Insurance

Generated: January 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062721

« Back to Dashboard

NDA 062721 describes NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE, which is a drug marketed by Bausch And Lomb, Perrigo Co Tennessee, and Alcon Pharms Ltd, and is included in three NDAs. It is available from fifteen suppliers. Additional details are available on the NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE profile page.

The generic ingredient in NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE is dexamethasone; neomycin sulfate; polymyxin b sulfate. There are thirty-nine drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the dexamethasone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 062721
Pharmacology for NDA: 062721
Suppliers and Packaging for NDA: 062721
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE dexamethasone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062721 ANDA Rebel Distributors Corp 21695-595 21695-595-05 5 mL in 1 BOTTLE, PLASTIC (21695-595-05)
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE dexamethasone; neomycin sulfate; polymyxin b sulfate SUSPENSION/DROPS;OPHTHALMIC 062721 ANDA Physicians Total Care, Inc. 54868-1070 54868-1070-1 5 mL in 1 BOTTLE, PLASTIC (54868-1070-1)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;OPHTHALMICStrength0.1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date:Nov 17, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Citi
Novartis
Harvard Business School
Express Scripts
Cipla
Farmers Insurance
McKinsey
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot